Pacific Biosciences Of California | PACB - Sales Revenues


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Pacific Biosciences Of California

Pacific Biosciences Of California reported $38.9M in Sales Revenues for its fiscal quarter ending in March of 2023.


Sales Change
Accelerate Diagnostics AXDX:US USD 2.81M 160K
Agilent A:US USD 1.72B 39M
Bruker BRKR:US USD 685.3M 23.1M
Danaher DHR:US USD 7.17B 1.2B
General Electric GE:US USD 14.49B 7.3B
Illumina ILMN:US USD 1.09B 4M
Myriad Genetics MYGN:US USD 181.2M 3.4M
NanoString Technologies NSTG:US USD 35.8M 1.38M
Pacific Biosciences Of California PACB:US USD 38.9M 11.55M
PerkinElmer PKI:US USD 675.07M 413.9M
Quidel QDEL:US USD 846.1M 20.4M
Roche Holding ROG:VX CHF 30.99B 1.31B
Standard Biotools Inc FLDM:US USD 25.12M 1.9M
Thermo Fisher Scientific TMO:US USD 10.71B 740M
Waters WAT:US USD 684.67M 173.84M